TABLE 1

CB, maximum daily dose, and Cmax of the tested compounds

Test compounds (10 μM) were incubated with human liver microsomes in the presence of NADPH (first arm), NADPH and UDPGA (second arm), or NADPH, UDPGA, and GSH (third arm) or with hepatocytes (fourth arm). The CB amounts were determined with duplicate incubations. Daily dose and Cmax represent the maximum daily dose and the maximum concentration at the maximum daily dose, respectively. Daily dose and Cmax are from the package inserts or the following references: 1) Maass et al., 1982; 2) Durand et al., 1992; 3) Boni et al., 1997; 4) Greene and Barbhaiya, 1997; 5) Fontana et al., 1998; 6) Kalgutkar and Soglia, 2005; 7) Walgren et al., 2005; and 8) Lammert et al., 2008.

CompoundCB
Daily DoseCmaxReference
1st2nd3rd4th
pmol/mg proteinmg/dayng/ml
Positive compounds
    Acetaminophen1791242816400082,400a6, 7
    Alpidem4401928810115065.7a2, 6, 7
    Bromfenac5110744221009240a3, 6, 7, 8
    Carbamazepine11990351812009000a6, 7
    Diclofenac12017359492003320a6, 7, 8
    Flutamide4774712253575078.0a6, 7
    Imipramine2712586310300280a6
    Nefazodone13649973062546002760a4, 6, 7, 8
    Tacrine264201471420078.5a5, 6, 7, 8
    Ticlopidine128611362496050019506, 7
    Tienilic acid5384871242850057,0001, 6, 7, 8
    Troglitazone117096727311860028206, 7
Negative compounds
    Acetylsalicylic acidN.D.N.D.N.D.33001840
    Caffeine34219009000b
    Dexamethasone445272262412020.9a
    IbuprofenN.D.N.D.N.D.260049,800a
    Losartan1051054019100801
    Paroxetine23518224195026.9a
    Pioglitazone2363025911452100a
    Rosiglitazone1189894229118598
    Sertraline49422616200142
    TheophyllineN.D.N.D.N.D.14006000a
    Venlafaxine5562225225a
    Zolpidem231486101202
  • N.D., CB for test compounds was lower than that for the control without NADPH and UDPGA.

  • a Cmax value normalized by dose.

  • b Cmax value normalized by body weight.